What are the causes of secondary polycythemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Secondary Polycythemia

Secondary polycythemia results from either hypoxia-driven compensatory erythropoiesis or hypoxia-independent pathologic EPO production, with chronic lung disease, sleep apnea, and smoking being the most common causes in clinical practice. 1

Hypoxia-Driven Causes

These conditions trigger compensatory erythropoiesis through tissue hypoxia and elevated EPO levels:

Pulmonary Causes

  • Chronic lung disease (COPD, pulmonary fibrosis) is among the most common causes of secondary polycythemia in clinical practice 1, 2
  • Obstructive sleep apnea causes chronic intermittent hypoxia leading to compensatory erythrocytosis, particularly in obese patients 1, 3
  • Hypoventilation syndromes including obesity hypoventilation syndrome produce chronic hypoxemia 1, 2

Cardiovascular Causes

  • Right-to-left cardiopulmonary shunts cause persistent hypoxemia and secondary erythrocytosis 1, 2

Environmental and Toxic Causes

  • High-altitude habitation leads to physiologic polycythemia as an adaptive response to reduced atmospheric oxygen 1, 2
  • Smoker's polycythemia is a real condition caused by chronic carbon monoxide exposure, which binds hemoglobin with 200-250 times greater affinity than oxygen, creating functional hypoxia 1, 2
  • Carbon monoxide poisoning creates the same functional hypoxic state 1, 2

Key Clinical Pearl

  • EPO levels are often initially elevated in hypoxia-driven causes but may return to normal range once hemoglobin stabilizes at a higher compensatory level, potentially causing diagnostic confusion 1
  • Smoker's polycythemia resolves with smoking cessation, with risk reduction beginning within 1 year and return to baseline after 5 years 1

Hypoxia-Independent Causes

These conditions produce EPO autonomously, independent of tissue oxygen levels:

Malignant Tumors

  • Renal cell carcinoma is the most common tumor causing pathologic EPO production 1, 2
  • Hepatocellular carcinoma produces EPO independently of hypoxia 1, 2
  • Cerebellar hemangioblastoma is a classic EPO-producing tumor 2
  • Pheochromocytoma can produce EPO 1, 2
  • Meningioma can produce EPO 1, 2
  • Parathyroid carcinoma produces EPO autonomously through pathologic mechanisms 1

Benign Tumors

  • Uterine leiomyomas (fibroids) can produce EPO despite being benign 1, 2

Post-Transplant

  • Post-renal transplant erythrocytosis (PRTE) is a recognized cause of secondary polycythemia 1

Iatrogenic Causes

  • Exogenous erythropoietic drugs (EPO, androgen preparations) cause secondary polycythemia 1
  • Doping with EPO or analogs is increasingly recognized in athletes 4, 5

Congenital Causes

These are rare genetic conditions presenting in younger patients:

  • High oxygen-affinity hemoglobinopathy (autosomal-dominant) causes tissue hypoxia despite normal oxygen saturation 1, 2
  • Chuvash polycythemia results from abnormal oxygen homeostasis with elevated EPO set point 1
  • EPOR mutations causing autosomal-dominant congenital polycythemia 1, 5
  • 2,3-DPG mutase deficiency impairs oxygen delivery to tissues 2, 5
  • Von Hippel-Lindau gene mutations affect oxygen sensing mechanisms 2

Diagnostic Algorithm

Step 1: Exclude apparent (relative) polycythemia by assessing for plasma volume depletion from dehydration, diarrhea, vomiting, diuretic use, or burns 1, 2

Step 2: Measure serum EPO level as the key discriminator—elevated EPO suggests secondary polycythemia, while low or inappropriately normal EPO suggests polycythemia vera 1, 2

Step 3: If EPO is elevated, evaluate for hypoxia using arterial blood gas or pulse oximetry, and obtain chest X-ray to assess for chronic lung disease 1, 2

Step 4: Consider sleep study (polysomnography) if obese, fatigued, or other clinical features suggest sleep apnea 1, 3

Step 5: If EPO elevated without hypoxia, obtain abdominal imaging (ultrasound or CT) to screen for renal cell carcinoma, hepatocellular carcinoma, or other EPO-producing tumors 1, 2

Step 6: In young patients without obvious secondary cause, consider hemoglobin electrophoresis for high oxygen-affinity variants and genetic testing for congenital causes 2

Critical Pitfalls to Avoid

  • Do not overlook smoking as a cause—smoker's polycythemia is a real condition that resolves with cessation, not just a relative polycythemia 1, 2
  • Do not misinterpret normal EPO levels in chronic hypoxic states—levels may normalize after hemoglobin stabilizes at a higher compensatory level, mimicking polycythemia vera 1
  • Do not assume "adequate sleep" rules out sleep apnea—patients with OSA are typically unaware of their sleep fragmentation and nocturnal hypoxemia 3
  • Do not rush to diagnose polycythemia vera without first excluding secondary causes, especially in patients with obesity, lung disease, or smoking history 3

References

Guideline

Secondary Polycythemia Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Polycythemia Causes and Diagnostic Approach

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Obstructive Sleep Apnea Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Polycythemia].

Deutsche medizinische Wochenschrift (1946), 2010

Research

Congenital and acquired polycythemias.

Deutsches Arzteblatt international, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.